AEDIFICA (AED.BR) Stock Fundamental Analysis
EBR:AED - Euronext Brussels - BE0003851681 - REIT - Currency: EUR
We assign a fundamental rating of 4 out of 10 to AED. AED was compared to 10 industry peers in the Diversified REITs industry. There are concerns on the financial health of AED while its profitability can be described as average. AED is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AED was profitable.
AED had a positive operating cash flow in the past year.
AED had positive earnings in each of the past 5 years.
AED had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 3.17%, AED is doing good in the industry, outperforming 65.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 5.62%, AED is in line with its industry, outperforming 55.00% of the companies in the same industry.
AED has a Return On Invested Capital (3.28%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for AED is below the industry average of 6.38%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.62% | ||
| ROIC | 3.28% |
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
1.3 Margins
AED has a better Profit Margin (60.60%) than 70.00% of its industry peers.
AED's Profit Margin has declined in the last couple of years.
The Operating Margin of AED (76.93%) is better than 67.50% of its industry peers.
AED's Operating Margin has been stable in the last couple of years.
AED has a Gross Margin of 97.67%. This is amongst the best in the industry. AED outperforms 95.00% of its industry peers.
In the last couple of years the Gross Margin of AED has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 76.93% | ||
| PM (TTM) | 60.6% | ||
| GM | 97.67% |
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
2. Health
2.1 Basic Checks
AED has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AED has about the same amount of shares outstanding.
The number of shares outstanding for AED has been increased compared to 5 years ago.
The debt/assets ratio for AED is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.83, we must say that AED is in the distress zone and has some risk of bankruptcy.
AED has a worse Altman-Z score (0.83) than 62.50% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that AED is somewhat dependend on debt financing.
AED's Debt to Equity ratio of 0.57 is fine compared to the rest of the industry. AED outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.83 |
ROIC/WACC0.55
WACC6%
2.3 Liquidity
A Current Ratio of 0.32 indicates that AED may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.32, AED is doing worse than 72.50% of the companies in the same industry.
AED has a Quick Ratio of 0.32. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.32, AED is doing worse than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.32 | ||
| Quick Ratio | 0.32 |
3. Growth
3.1 Past
AED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 106.32%, which is quite impressive.
AED shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.20% yearly.
The Revenue has grown by 9.26% in the past year. This is quite good.
Measured over the past years, AED shows a very strong growth in Revenue. The Revenue has been growing by 23.35% on average per year.
EPS 1Y (TTM)106.32%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%-16.97%
Revenue 1Y (TTM)9.26%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%13.14%
3.2 Future
The Earnings Per Share is expected to grow by 2.70% on average over the next years.
The Revenue is expected to grow by 5.06% on average over the next years.
EPS Next Y2.38%
EPS Next 2Y3.16%
EPS Next 3Y2.7%
EPS Next 5YN/A
Revenue Next Year5.99%
Revenue Next 2Y5.47%
Revenue Next 3Y5.06%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.30 indicates a correct valuation of AED.
Compared to the rest of the industry, the Price/Earnings ratio of AED is on the same level as its industry peers.
AED is valuated rather cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 12.57 indicates a correct valuation of AED.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AED is on the same level as its industry peers.
AED is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.3 | ||
| Fwd PE | 12.57 |
4.2 Price Multiples
62.50% of the companies in the same industry are cheaper than AED, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 21.29 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AED does not grow enough to justify the current Price/Earnings ratio.
AED has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.86
PEG (5Y)N/A
EPS Next 2Y3.16%
EPS Next 3Y2.7%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.10%, AED is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.79, AED is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.40, AED pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.1% |
5.2 History
The dividend of AED is nicely growing with an annual growth rate of 22.82%!
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
AED pays out 81.46% of its income as dividend. This is not a sustainable payout ratio.
The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP81.46%
EPS Next 2Y3.16%
EPS Next 3Y2.7%
EBR:AED (6/18/2025, 7:00:00 PM)
65.85
+0.6 (+0.92%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners40.83%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap3.13B
Analysts78.89
Price Target73.7 (11.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.1% |
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP81.46%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.66%
PT rev (3m)3.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.3 | ||
| Fwd PE | 12.57 | ||
| P/S | 9.26 | ||
| P/FCF | N/A | ||
| P/OCF | 12.6 | ||
| P/B | 0.86 | ||
| P/tB | 0.88 | ||
| EV/EBITDA | 21.29 |
EPS(TTM)4.04
EY6.14%
EPS(NY)5.24
Fwd EY7.96%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)5.23
OCFY7.94%
SpS7.11
BVpS76.61
TBVpS74.75
PEG (NY)6.86
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.62% | ||
| ROCE | 4.38% | ||
| ROIC | 3.28% | ||
| ROICexc | 3.29% | ||
| ROICexgc | 3.34% | ||
| OM | 76.93% | ||
| PM (TTM) | 60.6% | ||
| GM | 97.67% | ||
| FCFM | N/A |
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexcg growth 3Y6.29%
ROICexcg growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score8
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.85 | ||
| Cap/Depr | 8867.91% | ||
| Cap/Sales | 76.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.51% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.32 | ||
| Quick Ratio | 0.32 | ||
| Altman-Z | 0.83 |
F-Score8
WACC6%
ROIC/WACC0.55
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.32%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%-16.97%
EPS Next Y2.38%
EPS Next 2Y3.16%
EPS Next 3Y2.7%
EPS Next 5YN/A
Revenue 1Y (TTM)9.26%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%13.14%
Revenue Next Year5.99%
Revenue Next 2Y5.47%
Revenue Next 3Y5.06%
Revenue Next 5YN/A
EBIT growth 1Y8.46%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year12.16%
EBIT Next 3Y6.92%
EBIT Next 5YN/A
FCF growth 1Y88.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.26%
OCF growth 3Y7.82%
OCF growth 5Y22.86%